Arcturus Therapeutics Holdings Inc. SEC filings ARCT

Arcturus Therapeutics Holdings Inc. has 416 filings in SEC EDGAR's recent list, going back to Mar 18, 2019. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcturus Therapeutics Holdings Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Regulation FD disclosure
Sep 23, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure
Aug 25, 2026 Aug 25, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jul 2, 2026 Jun 26, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 5, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
May 7, 2026 May 1, 2026
DEF 14A Proxy statement Apr 24, 2026 Jun 5, 2026
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
S-3 Shelf registration Dec 30, 2025 —
8-K Current report
Officer or director change
Dec 15, 2025 Dec 11, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
NT 10-Q Filing Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure
Sep 26, 2025 Sep 26, 2025
8-K Current report
Regulation FD disclosure
Aug 29, 2025 Aug 29, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 6, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
DEF 14A Proxy statement Apr 25, 2025 Jun 6, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
S-8 Employee stock plan registration Jul 17, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 24, 2024 Jun 19, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2024 Jun 14, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
DEF 14A Proxy statement Apr 29, 2024 Jun 14, 2024
8-K Current report
Auditor change
Apr 5, 2024 Apr 5, 2024
8-K Current report
Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K/A Amended current report
Results of operations
Mar 14, 2024 Mar 7, 2024
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
8-K Current report
Officer or director change
Feb 23, 2024 Feb 20, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Material agreement, Other events
Sep 26, 2023 Sep 25, 2023
8-K Current report
Material agreement, Other events
Aug 14, 2023 Aug 10, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Aug 7, 2023 Aug 7, 2023
424B5 Prospectus supplement Aug 7, 2023 —
8-K Current report
Regulation FD disclosure
Jul 14, 2023 Jul 13, 2023
8-K Current report
Regulation FD disclosure
Jun 30, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 14, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
DEF 14A Proxy statement May 1, 2023 Jun 14, 2023
8-K Current report
Regulation FD disclosure
Apr 28, 2023 Apr 28, 2023
8-K Current report
Material agreement, New debt
Apr 21, 2023 Apr 21, 2023
8-K Current report
Regulation FD disclosure
Apr 11, 2023 Apr 11, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Agreement ended
Mar 17, 2023 Mar 14, 2023
EFFECT Filing Dec 30, 2022 —
CORRESP Letter to the SEC Dec 30, 2022 —
UPLOAD Letter from the SEC Dec 29, 2022 —
DEL AM Filing Dec 27, 2022 —
S-3 Shelf registration Dec 23, 2022 —
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 13, 2022 Dec 8, 2022
8-K Current report
Regulation FD disclosure
Dec 13, 2022 Dec 8, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Material agreement, Agreement ended
Nov 4, 2022 Oct 31, 2022
8-K Current report
Material agreement
Nov 2, 2022 Nov 1, 2022
8-K Current report
Material agreement
Sep 1, 2022 Aug 31, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
S-8 Employee stock plan registration Jun 30, 2022 —
8-K Current report
Material agreement, Shareholder vote results
Jun 24, 2022 Jun 21, 2022
DEFR14A Filing May 12, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
DEF 14A Proxy statement May 2, 2022 Jun 21, 2022
8-K Current report
Material agreement, Agreement ended, Other events
Apr 20, 2022 Apr 14, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Feb 17, 2022 Feb 17, 2022
8-K Current report
Officer or director change
Feb 11, 2022 Feb 9, 2022
8-K Current report
Regulation FD disclosure
Jan 11, 2022 Jan 11, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 13, 2021 Dec 7, 2021
8-K Current report
Other events
Nov 16, 2021 Nov 16, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Material agreement
Nov 1, 2021 Oct 27, 2021
S-8 Employee stock plan registration Oct 20, 2021 —
8-K Current report
Material agreement, New debt
Oct 5, 2021 Sep 29, 2021
8-K Current report
Agreement ended, Officer or director change
Aug 26, 2021 Aug 20, 2021
NT 10-Q Filing Aug 10, 2021 Jun 30, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2021 Aug 9, 2021
8-K Current report
Material agreement
Aug 4, 2021 Jul 29, 2021
8-K Current report
Shareholder vote results
Jun 22, 2021 Jun 18, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2021 May 10, 2021
DEF 14A Proxy statement Apr 30, 2021 Jun 18, 2021
8-K Current report
Officer or director change
Apr 26, 2021 Apr 21, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 1, 2021 Mar 1, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Unregistered share sale, Other events
Feb 22, 2021 Feb 17, 2021
8-K Current report
New debt
Feb 3, 2021 Jan 29, 2021
424B5 Prospectus supplement Dec 8, 2020 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 8, 2020 Dec 7, 2020
424B5 Prospectus supplement Dec 7, 2020 —
S-3ASR Automatic shelf registration Dec 7, 2020 —
8-K Current report
Material agreement
Dec 7, 2020 Dec 1, 2020
8-K Current report
Bylaw or fiscal year change
Nov 25, 2020 Nov 25, 2020
8-K Current report
Shareholder vote results
Nov 13, 2020 Nov 10, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Other events
Oct 15, 2020 Oct 14, 2020
DEF 14A Proxy statement Oct 13, 2020 Nov 10, 2020
PRE 14A Preliminary proxy statement Oct 2, 2020 Oct 2, 2020
8-K Current report
Other events
Oct 2, 2020 Sep 30, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Aug 18, 2020 Aug 17, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
S-8 Employee stock plan registration Aug 5, 2020 —
S-8 Employee stock plan registration Aug 5, 2020 —
424B5 Prospectus supplement Jul 30, 2020 —
8-K Current report
Material agreement
Jul 29, 2020 Jul 28, 2020
424B5 Prospectus supplement Jul 28, 2020 —
8-K Current report
Other events
Jul 24, 2020 Jul 23, 2020
EFFECT Filing Jun 26, 2020 —
CORRESP Letter to the SEC Jun 19, 2020 —
8-K Current report
Regulation FD disclosure
Jun 18, 2020 Jun 18, 2020
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 5, 2020
S-3/A Filing May 22, 2020 —
EFFECT Filing May 21, 2020 —
8-K Current report
Unregistered share sale, Regulation FD disclosure
May 21, 2020 May 20, 2020
CORRESP Letter to the SEC May 18, 2020 —
UPLOAD Letter from the SEC May 15, 2020 —
S-3 Shelf registration May 8, 2020 —
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEF 14A Proxy statement Apr 29, 2020 Jun 5, 2020
8-K Current report
Other events
Apr 21, 2020 Apr 17, 2020
424B5 Prospectus supplement Apr 17, 2020 —
8-K Current report
Material agreement, Agreement ended, Other events
Apr 17, 2020 Apr 15, 2020
S-3MEF Filing Apr 16, 2020 —
424B5 Prospectus supplement Apr 15, 2020 —
8-K Current report
Material agreement
Mar 27, 2020 Mar 27, 2020
424B5 Prospectus supplement Mar 27, 2020 —
10-K Annual report Mar 16, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 11, 2020 Mar 11, 2020
8-K Current report
Material agreement
Mar 4, 2020 Mar 4, 2020
SEC STAFF LETTER Filing Feb 24, 2020 —
SEC STAFF LETTER Filing Feb 3, 2020 —
8-K Current report
Regulation FD disclosure
Jan 10, 2020 Jan 10, 2020
UPLOAD Letter from the SEC Dec 16, 2019 —
S-3 Shelf registration Dec 12, 2019 —
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Regulation FD disclosure
Nov 7, 2019 Nov 7, 2019
8-K Current report
Material agreement, Shareholder vote results
Oct 31, 2019 Oct 25, 2019
DEF 14A Proxy statement Oct 1, 2019 Oct 25, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Sep 27, 2019 Sep 25, 2019
424B5 Prospectus supplement Sep 27, 2019 —
8-K Current report
Officer or director change, Other events
Sep 23, 2019 Sep 17, 2019
8-K Current report
Other events
Sep 16, 2019 Sep 16, 2019
8-K Current report
Regulation FD disclosure
Aug 15, 2019 Aug 15, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Aug 5, 2019 Aug 2, 2019
424B5 Prospectus supplement Aug 5, 2019 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 2, 2019 Aug 1, 2019
424B5 Prospectus supplement Aug 2, 2019 —
8-K Current report
Material agreement, Other events
Aug 1, 2019 Aug 1, 2019
EFFECT Filing Jul 29, 2019 —
8-K Current report
Material agreement, Agreement ended
Jul 29, 2019 Jul 26, 2019
CORRESP Letter to the SEC Jul 25, 2019 —
CT ORDER Filing Jul 18, 2019 —
UPLOAD Letter from the SEC Jun 27, 2019 —
S-3/A Filing Jun 26, 2019 —
S-3 Shelf registration Jun 21, 2019 —
S-8 Employee stock plan registration Jun 21, 2019 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Jun 20, 2019 Jun 18, 2019
8-K Current report
Regulation FD disclosure
Jun 19, 2019 Jun 19, 2019
8-K12B Filing Jun 14, 2019 Jun 12, 2019
EFFECT Filing Apr 12, 2019 —
424B3 Prospectus Apr 12, 2019 —
CORRESP Letter to the SEC Apr 11, 2019 —
S-4/A Filing Apr 11, 2019 —
S-4 Registration for a merger or exchange Mar 18, 2019 —

Showing 195 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1768224

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.